Nefopam is a non-opiate analgesic commonly used for the treatment of moderate to severe pain. A case of a 37-year-old male who was found dead in the morning is presented. An autopsy was performed and femoral venous blood, heart blood, urine, and vitreous humour were submitted for toxicological analysis. A general drug screen detected the presence of .
Introduction
To date, there have previously been 6 reports of fatal overdoses of nefopam mainly in the UK (1) (2) (3) (4) , but also in France (5) and New Zealand (6) . This study is the first to quantify nefopam in vitreous humour as well as in unpreserved femoral and cardiac blood. This study is also only the second study to report the levels of nefopam in unpreserved femoral blood.
Femoral blood is generally regarded as the sample in which the concentration of drugs changes the least between the time of death and the postmortem period. The femoral blood is therefore the best sample in which to accurately determine the amount of drug present at the time of death (7) . This paper describes the autopsy and toxicological findings of a nefopam poisoning fatality.
Nefopam was detected and quantitated in unpreserved and preserved femoral blood, unpreserved cardiac blood and we report for the first time the detection and quantitation of nefopam in vitreous humour. The detection and quantitation of nefopam was carried out by a validated method using high-performance liquid chromatography with diode-array detection (HPLC-DAD).
Case report
A 37 year old male was found at home lying on his stomach with no sign of life. He suffered from chronic pain and had a history of depression with a previous attempt at suicide via overdose. There was no expression by the deceased that he was intending to take his own life in the period before the death. Various medications were recovered from the scene and included naproxen, citalopram, gabapentin, omeprazole, paracetamol and diazepam. Two months prior to his death he was prescribed Nefopam Hydrochloride.
Internal examination at autopsy revealed marked degenerative narrowing and hardening of the arteries supplying blood to the muscle of the heart (atherosclerotic coronary artery disease). There was no evidence of either recent or old heart attack (no acute infraction or myocardial fibrosis). Both lungs were heavy and congested with a large amount of fluid within them (pulmonary oedema). No tablets or tablet residue was discovered within the stomach or first part of the intestine. Histopathological examination of the retained tissues confirmed their macroscopic appearances at autopsy. There were small areas of scaring in the heart muscle in keeping with old injury due to poor flow (myocardial fibrosis) and evidence of narrowing of the vessels (atherosclerosis).
Experimental

Postmortem Samples
As part of routine autopsy procedures unpreserved femoral and cardiac blood were collected. Preserved samples (2.5% Fluoride/Oxalate) of vitreous humour, femoral blood and urine were also collected to help prevent postmortem drug degradation and/or ethanol formation.
Analytical materials and methods
A stock solution of Nefopam (LGC standards, Teddington, UK) was prepared at a concentration of 1mg/ml in methanol (Fisher Scientific, Loughborough, U.K) and stored at 4°C in an amber vial. This stock solution was used to prepare a seven point calibration curve Data acquired at 230 nm wavelength was used for all quantitation
Method Validation
The Nefopam quantification method was validated to meet ISO17025 standard requirement and the parameters assessed were as described previously (9): linearity (r 2 =0.999) ( 
Discussion
Nefopam (Fig 1A) (18, 19) . Pharmacologically, the analgesic effect of nefopam has been found to be 10 times more potent than aspirin (20) however it is possible to get an estimate using the data from the study by Aymard et al. (25) were the mean Vd is 535 l and the mean weight of the subjects is 74 kg. This gives a ~Vd of 
